Tactile Systems Technology reports Q3 2026 results and raises adjusted EBITDA outlook
Tactile Systems Technology posted third‑quarter revenue of $91.9 million, a 7% year‑over‑year increase, while net income fell to $7.2 million, or $0.31 per diluted share. Airway‑clearance sales dropped 25.1% to $10 million due to an inventory transition, but lymphedema revenue grew 13%. The company kept its full‑year 2026 revenue target of $360 million‑$366 million and lifted its adjusted EBITDA guidance to $50 million‑$52 million.
Why it matters
The raised EBITDA range signals higher profitability expectations for the year, which may improve cash‑flow forecasts for investors. Maintaining the revenue outlook while acknowledging a dip in airway‑clearance sales highlights a shift in product mix that could affect future margin trends.
Key facts
- 1Q3 revenue was $91.9 million, up 7% YoY. finance.yahoo.com
- 2Airway‑clearance revenue fell 25.1% to $10 million. finance.yahoo.com
- 3Lymphedema revenue grew 13% YoY. finance.yahoo.com
- 4Gross margin expanded to 76.7%, up 90 basis points from 75.8% a year earlier. finance.yahoo.com
- 5Operating expenses were $60.9 million, a 12.7% increase year over year. finance.yahoo.com
- 6Net income was $7.2 million, or $0.31 per diluted share. finance.yahoo.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.